Edward E. Walsh
Impact in
- Epidemiology top 0.02%
- Respiratory viral infections research
- Influenza Virus Research Studies
- Pneumonia and Respiratory Infections
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
Papers in
- Epidemiology 189
- Respiratory viral infections research 169
- Influenza Virus Research Studies 11
- Pneumonia and Respiratory Infections 9
- Sepsis Diagnosis and Treatment 6
-
- SARS-CoV-2 and COVID-19 Research 13
- COVID-19 Clinical Research Studies 6
- Infection Control in Healthcare 5
- Co-authors
- Ann Regina Falsey (116 shared papers)Maria A. Formica (17 shared papers)Jacob J. Schlesinger (13 shared papers)MICHAEL W. BRANDRISS (13 shared papers)Patricia Hennessey (5 shared papers)Christopher Cox (1 shared paper)Larry J. Anderson (9 shared papers)Brian R. Murphy (14 shared papers)
- Journals
- The Journal of Infectious Diseases (61 papers)Journal of Clinical Microbiology (13 papers)Journal of General Virology (10 papers)Vaccine (9 papers)Clinical Infectious Diseases (8 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Edward E. Walsh
227 papers receiving 22.6k citations
Edward E. Walsh's Hit Papers
Peers
Comparison fields: 5 of 145
- Epidemiology 15.1k
- Infectious Diseases 4k
- Immunology 2.3k
- Applied Microbiology and Biotechnology 162
- Microbiology 271
Countries citing papers authored by Edward E. Walsh
This map shows the geographic impact of Edward E. Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward E. Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward E. Walsh more than expected).
Fields of papers citing papers by Edward E. Walsh
This network shows the impact of papers produced by Edward E. Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward E. Walsh. The network helps show where Edward E. Walsh may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward E. Walsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 230 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates Hit paper breakdown → | 2020 | 2111 |
| 2 | Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults Hit paper breakdown → | 2005 | 1841 |
| 3 | Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus Hit paper breakdown → | 2000 | 1390 |
| 4 | Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults Hit paper breakdown → | 2020 | 1270 |
| 5 | Immunity to and Frequency of Reinfection with Respiratory Syncytial Virus Hit paper breakdown → | 1991 | 664 |
| 6 | 2000 | 541 | |
| 7 | 2003 | 494 | |
| 8 | Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults Hit paper breakdown → | 2023 | 477 |
| 9 | Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral Infection Hit paper breakdown → | 1983 | 451 |
| 10 | 2015 | 416 | |
| 11 | 2010 | 379 | |
| 12 | The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates Hit paper breakdown → | 2018 | 372 |
| 13 | 2000 | 360 | |
| 14 | Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults Hit paper breakdown → | 2023 | 351 |
| 15 | SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 Hit paper breakdown → | 2021 | 289 |
| 16 | 1990 | 287 | |
| 17 | 1986 | 285 | |
| 18 | 1986 | 273 | |
| 19 | 1987 | 266 | |
| 20 | 1983 | 262 |
About Edward E. Walsh
Edward E. Walsh is a scholar working on Epidemiology, Infectious Diseases, Applied Microbiology and Biotechnology, Microbiology and Immunology, having authored 230 papers that have together received 24.2k indexed citations. Recurring topics across this work include Respiratory viral infections research (169 papers), SARS-CoV-2 and COVID-19 Research (13 papers), Influenza Virus Research Studies (11 papers), Pneumonia and Respiratory Infections (9 papers), Sepsis Diagnosis and Treatment (6 papers), Mosquito-borne diseases and control (6 papers), COVID-19 Clinical Research Studies (6 papers) and Infection Control in Healthcare (5 papers). The work is most often cited by research in Epidemiology (15.1k citations), Infectious Diseases (4k citations), Immunology (2.3k citations), Applied Microbiology and Biotechnology (162 citations) and Microbiology (271 citations). Edward E. Walsh has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Ann Regina Falsey, Maria A. Formica, Jacob J. Schlesinger, MICHAEL W. BRANDRISS, Patricia Hennessey, Christopher Cox, Larry J. Anderson, Brian R. Murphy, Derick R. Peterson and Charles B. Hall. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Clinical Microbiology, Journal of General Virology, Vaccine and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.